StemCell Institute Inc. (TYO:7096)

Japan flag Japan · Delayed Price · Currency is JPY
935.00
-21.00 (-2.20%)
Sep 9, 2025, 3:30 PM JST
-2.20%
Market Cap9.80B
Revenue (ttm)2.70B
Net Income (ttm)250.00M
Shares Out10.25M
EPS (ttm)24.46
PE Ratio39.08
Forward PEn/a
Dividend25.00 (2.65%)
Ex-Dividend DateSep 27, 2024
Volume33,300
Average Volume57,390
Open956.00
Previous Close956.00
Day's Range930.00 - 957.00
52-Week Range911.00 - 1,923.00
Beta0.53
RSI37.48
Earnings DateNov 7, 2025

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 117
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7096
Full Company Profile

Financial Performance

In 2024, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.

Financial Statements

News

There is no news available yet.